As of June 4, 2025, Second Sight Medical Products Inc (EYES) reports a Current Ratio of 28.64.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Second Sight Medical Products Inc's Current Ratio
Over recent years, Second Sight Medical Products Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2021-12-31 | 28.64 |
| 2020-12-31 | 0.83 |
| 2019-12-31 | 1.88 |
| 2018-12-31 | 1.27 |
| 2017-12-31 | 1.99 |
This slight downward trend highlights how Second Sight Medical Products Inc manages its short-term assets and liabilities over time.
Comparing Second Sight Medical Products Inc's Current Ratio to Peers
To better understand Second Sight Medical Products Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Second Sight Medical Products Inc (EYES) | 28.64 |
| Rewalk Robotics Ltd (RWLK) | 15.17 |
| Delcath Systems Inc (DCTH) | 12.01 |
| Soliton Inc (SOLY) | 11.44 |
| Sensus Healthcare Inc (SRTS) | 9.64 |
| IRadimed Corp (IRMD) | 8.84 |
Compared to its competitors, Second Sight Medical Products Inc's Current Ratio is higher than all peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.